Comirnaty Concentrate For Dispersion For Injection 0,3 mL Concentrate for dispersion for injection
PDF Leaflet Revision Date: 23 August 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Active immunisation to prevent COVID-19 in individuals 12 years and older.
Dosage (summary)
Primary course: 2 doses (0.3 mL each) IM, 3 weeks apart; booster: 0.3 mL IM.
Special Populations
- Elderly
- Severely immunocompromised
Pregnancy & Breastfeeding
Can be used during pregnancy and breastfeeding; no adverse effects expected.
Contraindications
- Hypersensitivity to vaccine components
Common side effects
- Injection site pain
- Fatigue
- Headache
- Myalgia
- Chills
Counselling Points
- Monitor for 15 mins post-vaccination
- Report any severe reactions immediately
Serious warnings
- Risk of anaphylaxis
- Increased risk of myocarditis and pericarditis
On This Page
Connecting to Document Server
Decrypting and optimizing pharmaceutical leaflet...
Medinsert AI
Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
